U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
178321178321Air Cleaners for Children and Adolescents With Asthma and Dog AllergyCompletedNo Results AvailableAsthma|AllergyDevice: IQAir Allergen 100 Air cleanershttps://ClinicalTrials.gov/show/NCT00220753
178322178322Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedHas ResultsPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingDrug: Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified|Drug: Albumin (Human) 25%, United States Pharmacopeia (USP)https://ClinicalTrials.gov/show/NCT00220740
178323178323Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITPCompletedHas ResultsPurpura, Thrombocytopenic, IdiopathicDrug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purifiedhttps://ClinicalTrials.gov/show/NCT00220727
178324178324PREvent First Episode Relapse (PREFER)Active, not recruitingNo Results AvailableSchizophreniaDrug: atypical antipsychotics:oral vs. long-acting route|Behavioral: Family Psychoeducationhttps://ClinicalTrials.gov/show/NCT00220714
178325178325Escitalopram in the Treatment of Dysthymic Disorder, Double BlindCompletedHas ResultsDysthymic DisorderDrug: Lexapro (escitalopram)https://ClinicalTrials.gov/show/NCT00220701
178326178326Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?CompletedNo Results AvailableCancerDevice: Acupressure Wristbandshttps://ClinicalTrials.gov/show/NCT00220688
178327178327Erythropoietin Spinal Cord Compression Randomized TrialTerminatedNo Results AvailableNerve Compression SyndromesDrug: Erythropoietin infusionhttps://ClinicalTrials.gov/show/NCT00220675
178328178328The Efficacy of Readiness and Motivation Therapy in Individuals With Anorexia Nervosa and Bulimia NervosaActive, not recruitingNo Results AvailableAnorexia Nervosa|Bulimia NervosaBehavioral: Readiness and Motivation Therapyhttps://ClinicalTrials.gov/show/NCT00220662
178329178329Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNo Results AvailablePancreatic NeoplasmsDrug: gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatinhttps://ClinicalTrials.gov/show/NCT00220649
178330178330Abilify as an Adjunctive Treatment for Refractory DepressionCompletedHas ResultsDepressive Disorder, MajorDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT00220636
178331178331Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major DepressionRecruitingNo Results AvailableMajor DepressionDrug: antidepressant medications, flexible drug choice|Behavioral: CBT, Psychodynamic or Supportive Psychotherapyhttps://ClinicalTrials.gov/show/NCT00220623
178332178332REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSIONRecruitingNo Results AvailableDepressionDevice: Transcranial magnetic stimulationhttps://ClinicalTrials.gov/show/NCT00220610
178333178333Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual AbuseCompletedNo Results AvailableAlcoholism|Child Abuse, Sexual|Sexual Abuse|Sexual Behavior|Sexually Transmitted Diseases, ViralBehavioral: Trauma-focused group therapyhttps://ClinicalTrials.gov/show/NCT00220597
178334178334An Open-Label Trial of Donepezil in Fragile X SyndromeCompletedNo Results AvailableFragile X SyndromeDrug: donepezilhttps://ClinicalTrials.gov/show/NCT00220584
178335178335CARESS in Acute Myocardial InfarctionCompletedNo Results AvailableMyocardial InfarctionDevice: Coronary Angioplasty (PTCA)https://ClinicalTrials.gov/show/NCT00220571
178336178336GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary OcclusionsActive, not recruitingNo Results AvailableCoronary Artery DiseaseDevice: Coronary placement of bare metal stent vs. drug eluting stenthttps://ClinicalTrials.gov/show/NCT00220558
178337178337Comparison Between Laparoscopic Ovarian Diathermy and Clomiphene Citrate in Women With Anovulatory PCOSCompletedNo Results AvailablePolycystic Ovary SyndromeProcedure: Laparoscopic ovarian diathermyhttps://ClinicalTrials.gov/show/NCT00220545
178338178338Folate and Protection Against Cervical CancerTerminatedNo Results AvailableCervical CancerDrug: Folic acid with riboflavinhttps://ClinicalTrials.gov/show/NCT00220532
178339178339Lactobacillus GG Supplementation During Pediatric Burn InjuriesTerminatedNo Results AvailableBurnsDrug: Lactobacillus GGhttps://ClinicalTrials.gov/show/NCT00220519
178340178340Fatigue Treatment Using ProvigilRecruitingNo Results AvailableAll Multiple Sclerosis PatientsDrug: Provigilhttps://ClinicalTrials.gov/show/NCT00220506
178341178341Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) PatientsRecruitingNo Results AvailableRelapsing Remitting Multiple Sclerosis|Multiple Sclerosis, Chronic ProgressiveDrug: Ritalinhttps://ClinicalTrials.gov/show/NCT00220493
178342178342A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionRecruitingNo Results AvailableDepressive Disorder, MajorDrug: escitalopramhttps://ClinicalTrials.gov/show/NCT00220480
178343178343Cognitive Effects of Aerobic Exercise for MCI AdultsCompletedNo Results AvailableMild Cognitive ImpairmentBehavioral: Aerobic exercisehttps://ClinicalTrials.gov/show/NCT00220467
178344178344Effect of Estrogen & Stress for Postmenopausal WomenCompletedNo Results AvailableAgingDrug: Climara|Drug: Hydrocortonehttps://ClinicalTrials.gov/show/NCT00220454
178345178345Cognitive Effects of Aerobic Exercise for IGT AdultsCompletedNo Results AvailableImpaired Glucose ToleranceBehavioral: Aerobic exercisehttps://ClinicalTrials.gov/show/NCT00220441
178346178346T-Cell Vaccination in Multiple Sclerosis (MS)RecruitingNo Results AvailableMultiple SclerosisBiological: T-Cell Vaccinationhttps://ClinicalTrials.gov/show/NCT00220428
178347178347A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary GeneralizationCompletedNo Results AvailablePartial Seizures With or Without Secondary GeneralizationDrug: SPM 927https://ClinicalTrials.gov/show/NCT00220415
178348178348Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder SyndromeCompletedNo Results AvailableOveractive Bladder SyndromeDrug: SPM 907https://ClinicalTrials.gov/show/NCT00220402
178349178349Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension PhaseCompletedNo Results AvailableOveractive BladderDrug: SPM 907https://ClinicalTrials.gov/show/NCT00220389
178350178350Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder SyndromeCompletedNo Results AvailableOveractive Bladder SyndromeDrug: SPM 907https://ClinicalTrials.gov/show/NCT00220376

* Görseller ve İçerik tekif hakkına sahip olabilir